epitope mapping near the N-terminus of CLLU1 of human origin
Modification Notes
Chronic lymphocytic leukemia (CLL) is an incurable disease characterized by the presence of small mature lymphocytes, intense accumulation of monoclonal B cells and a characteristic CD5 and CD19 co-expression phenotype. While the clinical course of CLL can be highly variable, a CLL specific protein known as CLLU1 (chronic lymphocytic leukemia up-regulated 1) is expressed in CLL patients, with high CLLU1 expression associated with shorter overall survival. Consisting of 121 amino acids, CLLU1 has been predicted to interact with interleukin 4 receptor (IL-4R) and is encoded by a gene located on human chromosome 12, which encodes over 1,100 genes and comprises approximately 4.5% of the human genome. Chromosome 12 is associated with a variety of diseases and afflictions, including hypochondrogenesis, achondrogenesis, Kniest dysplasia, Noonan syndrome and trisomy 12p.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of CLLU1 of human origin by WB, IP, IF and ELISA non cross-reactive with CLLU1OS:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope mapping near the N-terminus of CLLU1 of human origin
Tissue Specificity
epitope mapping near the N-terminus of CLLU1 of human origin